JP2015529454A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015529454A5 JP2015529454A5 JP2015524428A JP2015524428A JP2015529454A5 JP 2015529454 A5 JP2015529454 A5 JP 2015529454A5 JP 2015524428 A JP2015524428 A JP 2015524428A JP 2015524428 A JP2015524428 A JP 2015524428A JP 2015529454 A5 JP2015529454 A5 JP 2015529454A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- nme1
- nme family
- state
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261675292P | 2012-07-24 | 2012-07-24 | |
| US61/675,292 | 2012-07-24 | ||
| US201261677442P | 2012-07-30 | 2012-07-30 | |
| US61/677,442 | 2012-07-30 | ||
| US201261679021P | 2012-08-02 | 2012-08-02 | |
| US61/679,021 | 2012-08-02 | ||
| US201261683155P | 2012-08-14 | 2012-08-14 | |
| US61/683,155 | 2012-08-14 | ||
| US201261684654P | 2012-08-17 | 2012-08-17 | |
| US61/684,654 | 2012-08-17 | ||
| US201261693712P | 2012-08-27 | 2012-08-27 | |
| US61/693,712 | 2012-08-27 | ||
| PCT/US2012/060684 WO2013059373A2 (en) | 2011-10-17 | 2012-10-17 | Media for stem cell proliferation and induction |
| USPCT/US2012/060684 | 2012-10-17 | ||
| PCT/US2013/051899 WO2014018679A2 (en) | 2012-07-24 | 2013-07-24 | Nme variant species expression and suppression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019090368A Division JP2019141100A (ja) | 2012-07-24 | 2019-05-13 | Ｎｍｅバリアント種の発現および抑制 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015529454A JP2015529454A (ja) | 2015-10-08 |
| JP2015529454A5 true JP2015529454A5 (enExample) | 2016-09-15 |
| JP6546087B2 JP6546087B2 (ja) | 2019-07-17 |
Family
ID=49997968
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015524428A Active JP6546087B2 (ja) | 2012-07-24 | 2013-07-24 | Ｎｍｅバリアント種の発現および抑制 |
| JP2019090368A Pending JP2019141100A (ja) | 2012-07-24 | 2019-05-13 | Ｎｍｅバリアント種の発現および抑制 |
| JP2021132192A Active JP7386210B2 (ja) | 2012-07-24 | 2021-08-16 | Ｎｍｅバリアント種の発現および抑制 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019090368A Pending JP2019141100A (ja) | 2012-07-24 | 2019-05-13 | Ｎｍｅバリアント種の発現および抑制 |
| JP2021132192A Active JP7386210B2 (ja) | 2012-07-24 | 2021-08-16 | Ｎｍｅバリアント種の発現および抑制 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20150203823A1 (enExample) |
| EP (2) | EP2877586A4 (enExample) |
| JP (3) | JP6546087B2 (enExample) |
| CN (2) | CN111849874A (enExample) |
| AU (2) | AU2013295811A1 (enExample) |
| CA (1) | CA2880010A1 (enExample) |
| IL (1) | IL236901B (enExample) |
| SG (2) | SG10201700593YA (enExample) |
| WO (1) | WO2014018679A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4086338A1 (en) | 2011-03-17 | 2022-11-09 | Minerva Biotechnologies Corporation | Method for making pluripotent stem cells |
| WO2013059373A2 (en) | 2011-10-17 | 2013-04-25 | Minerva Biotechnologies Corporation | Media for stem cell proliferation and induction |
| EP3038462B1 (en) * | 2013-08-12 | 2023-03-15 | Minerva Biotechnologies Corporation | Method for enhancing tumor growth |
| EP4050103A1 (en) * | 2014-04-07 | 2022-08-31 | Minerva Biotechnologies Corporation | Anti-nme antibody |
| JP6895890B2 (ja) * | 2015-02-10 | 2021-06-30 | ミネルバ バイオテクノロジーズ コーポレーション | ヒト化抗ｍｕｃ１＊ 抗体 |
| CN109081863A (zh) * | 2018-08-01 | 2018-12-25 | 西北民族大学 | 抗癌活性物质放线菌素fgr的分离鉴定方法 |
| CN113727602B (zh) | 2019-02-04 | 2023-10-03 | 米纳瓦生物技术公司 | 抗nme抗体及治疗癌症或癌症转移的方法 |
| IL298780A (en) | 2020-06-08 | 2023-02-01 | Minerva Biotechnologies Corp | Anti-nme antibody and method of treating cancer or cancer metastasis |
| CN116075318A (zh) | 2020-06-26 | 2023-05-05 | 米纳瓦生物技术公司 | 抗nme抗体及治疗癌症或癌症转移的方法 |
| WO2023201234A2 (en) | 2022-04-12 | 2023-10-19 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2329822A1 (en) * | 2001-09-05 | 2011-06-08 | Minerva Biotechnologies Corporation | Compositions and methods of treatment of cancer |
| EP1375661A1 (en) * | 2002-06-17 | 2004-01-02 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | The role of the N-myc - nm23H1/nm23H2 - cdc42 pathway in proliferation, differentiation and treatment of cancer |
| CN101273060A (zh) * | 2005-06-24 | 2008-09-24 | 美国政府（由卫生和人类服务部、国立卫生研究院的部长所代表） | 通过靶向肿瘤坏死因子受体的前配体装配域(plad)来缓解炎性关节炎 |
| JP2008099662A (ja) * | 2006-09-22 | 2008-05-01 | Institute Of Physical & Chemical Research | 幹細胞の培養方法 |
| WO2008067065A2 (en) * | 2006-10-19 | 2008-06-05 | Shiv Srivastava | Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers |
| US20090075926A1 (en) * | 2006-12-06 | 2009-03-19 | Bamdad Cynthia C | Method for identifying and manipulating cells |
| US8273722B2 (en) | 2007-07-13 | 2012-09-25 | Dharmacon, Inc. | Enhanced biotherapeutic production using inhibitory RNA |
| KR20140101876A (ko) * | 2008-10-09 | 2014-08-20 | 미네르바 바이오테크놀로지 코포레이션 | 세포내에서 다능성을 유도하기 위한 방법 |
| EA026732B1 (ru) * | 2009-06-11 | 2017-05-31 | Минерва Байотекнолоджиз Корпорейшн | Способы культивирования стволовых клеток и клеток-предшественников |
| US20120156246A1 (en) * | 2010-06-16 | 2012-06-21 | Bamdad Cynthia C | Reprogramming cancer cells |
| JP6748430B2 (ja) * | 2012-07-13 | 2020-09-02 | ミネルバ バイオテクノロジーズ コーポレーション | より未分化状態への細胞の誘導方法 |
-
2013
- 2013-07-24 CA CA2880010A patent/CA2880010A1/en active Pending
- 2013-07-24 AU AU2013295811A patent/AU2013295811A1/en not_active Abandoned
- 2013-07-24 CN CN202010752407.5A patent/CN111849874A/zh active Pending
- 2013-07-24 WO PCT/US2013/051899 patent/WO2014018679A2/en not_active Ceased
- 2013-07-24 CN CN201380049792.5A patent/CN104995518A/zh active Pending
- 2013-07-24 SG SG10201700593YA patent/SG10201700593YA/en unknown
- 2013-07-24 JP JP2015524428A patent/JP6546087B2/ja active Active
- 2013-07-24 EP EP13823099.0A patent/EP2877586A4/en active Pending
- 2013-07-24 EP EP22198880.1A patent/EP4206318A1/en not_active Withdrawn
- 2013-07-24 SG SG11201606118SA patent/SG11201606118SA/en unknown
-
2015
- 2015-01-23 US US14/604,579 patent/US20150203823A1/en not_active Abandoned
- 2015-01-25 IL IL236901A patent/IL236901B/en active IP Right Grant
-
2019
- 2019-05-02 AU AU2019203098A patent/AU2019203098B2/en active Active
- 2019-05-13 JP JP2019090368A patent/JP2019141100A/ja active Pending
-
2021
- 2021-08-16 JP JP2021132192A patent/JP7386210B2/ja active Active
-
2022
- 2022-09-27 US US17/935,854 patent/US20230049461A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015529454A5 (enExample) | ||
| Glass et al. | MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart | |
| Huang et al. | Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction | |
| Lee et al. | Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression | |
| Jee et al. | Silencing of miR20a is crucial for Ngn1-mediated neuroprotection in injured spinal cord | |
| Wang et al. | Diverse effects of platelet-derived growth factor-BB on cell signaling pathways | |
| AU2011311344B2 (en) | Short RNA molecules | |
| Plowright et al. | Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents | |
| Bonnet et al. | Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases | |
| CN106978415B (zh) | 转运rna片段及其应用 | |
| Hunkler et al. | Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration | |
| CN108117585B (zh) | 一种靶向导入siRNA促进乳腺癌细胞凋亡的多肽 | |
| EP2794882A1 (en) | microRNAs FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION | |
| CN105492598A (zh) | 与细胞的抗衰老相关的生物分子群 | |
| CN108882705A (zh) | 基于经由来自人间充质干细胞(hMSC)的间隙连接递送寡核苷酸的癌症治疗 | |
| Bei et al. | SR proteins in cancer: function, regulation, and small inhibitor | |
| Lou et al. | Current status of nucleic acid therapy and its new progress in cancer treatment | |
| Choong et al. | The roles of non-coding RNAs in cardiac regenerative medicine | |
| Dong et al. | Non‐coding RNAs in cardiomyocyte proliferation and cardiac regeneration: dissecting their therapeutic values | |
| Fratini et al. | Oncogenic functions of ZEB1 in pediatric solid cancers: interplays with microRNAs and long noncoding RNAs | |
| JPWO2011111824A1 (ja) | マイクロｒｎａを用いた心筋細胞の増殖方法 | |
| JP7718819B2 (ja) | 成体幹細胞の拡大と誘導のインビトロでの誘発 | |
| CN112843082B (zh) | Dna四面体在制备治疗糖尿病的药物中的用途 | |
| Hudson et al. | The non-coding road towards cardiac regeneration | |
| CN104830863A (zh) | 一种抑制FABP4基因表达的siRNA及其应用 |